Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

Author： Shirota Hidekazu   Klinman Dennis M  

Publisher： Future Medicine

ISSN： 1750-743X

Source： Immunotherapy, Vol.5, Iss.8, 2013-08, pp. : 787-789

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Immunotherapy of asthma using CpG oligodeoxynucleotides

By Kline Joel  

Immunologic Research, Vol. 39, Iss. 1-3, 2007-11 ,pp. : 279-286

Humana Press, Inc

Access to resources Recommend Favorite

Toll-like Receptor 9, CpG DNA and Innate Immunity

By  

Current Molecular Medicine, Vol. 2, Iss. 6, 2002-09 ,pp. : 545-556

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of the Tumor Microenvironment on the Efficacy of Tumor Immunotherapy

By Neeson Paul   Paterson Yvonne  

Immunological Investigations, Vol. 35, Iss. 3-4, 2006-12 ,pp. : 359-394

Informa Healthcare

Access to resources Recommend Favorite

A comparison of nanoparticullate CpG immunotherapy with and without allergens in spontaneously equine asthma‐affected horses, an animal model

By  

Immunity, Inflammation And Disease, Vol. 6, Iss. 1, 2018-03 ,pp. : 81-96

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor-Derived Microvesicles and the Cancer Microenvironment

By  

Current Molecular Medicine, Vol. 13, Iss. 1, 2013-01 ,pp. : 58-67

Bentham Science Publishers

Access to resources Recommend Favorite